Testing kit and testing method for early screening or assisting diagnosis of urinary system diseases as well as applications of testing kit and testing method
A technique for urinary system diseases and detection kits is applied in the field of detection kits for urinary system disease markers, which can solve the problems that protein markers are not widely used clinically and the source of urine protein is complex, and achieves unique and large detection methods. Market prospects, highly specific effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0141] This example illustrates that urine is selected as the research object for finding stable urinary protein markers in healthy people, and the stable protein markers in the urine of healthy people are used as indicators for early screening of urinary system diseases.
[0142] 1. Experimental method
[0143] 1. Screening of healthy donors
[0144] 100 healthy men and 100 healthy women were selected from the students of Chongqing Third Military Medical University. For specific physical examination indicators, see Table 1.
[0145] Table I
[0146]
[0147] 2. Specimen collection
[0148] Urine samples were collected every two months for a total of 3 collections. Collect 50ml of mid-morning urine each time at 8:00am, centrifuge at 3000rpm / min for 20 minutes at 4°C, keep the supernatant, and store at 4°C.
[0149] 3. Treatment of urine
[0150] Immediately after urine collection, one protease inhibitor cocktail tablet (Complete™; Roche Diagnostics, Mannheim, Germany) ...
Embodiment 2
[0185] This embodiment provides multiple embodiments of the kit of the present invention, and those skilled in the art can modify these embodiments according to the embodiments exemplified below in conjunction with the teachings of the present invention, and the scope of the present invention also includes these modifications implementation plan.
[0186] For the convenience of description, in Table 6 below, if not specified, monoclonal antibody is used as an example for the capture reagent of antibody-antigen binding mode; high-affinity receptor or ligand is used as an example for receptor-ligand binding mode. At the same time, in order to simplify the description, the kits listed in Table 6 only list the main components, such as capture reagents, detection reagents, detectable marker molecules, etc., while other optional components such as diluents, buffers, cleaning agents, etc. are omitted. At the same time, only the detection methods of detectable marker molecules are giv...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com